Corticostriatal circuit dysfunction in Huntington’s disease: intersection of glutamate, dopamine and calcium

Author： Miller Benjamin Ray   Bezprozvanny Ilya  

Publisher： Future Medicine

ISSN： 1479-6708

Source： Future Neurology, Vol.5, Iss.5, 2010-09, pp. : 735-756

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Progressive striatal and cortical dopamine receptor dysfunction in Huntington’s disease: a PET study

By Piccini P.  

Brain, Vol. 126, Iss. 5, 2003-05 ,pp. : 1127-1135

Oxford University Press

Access to resources Recommend Favorite

Spotlight on Huntington’s Disease

By Strupp Michael  

Journal of Neurology, Vol. 251, Iss. 1, 2004-01 ,pp. : 120-121

Springer Publishing Company

Access to resources Recommend Favorite

HUNTINGTON’S DISEASE

By Barker Roger  

Brain, Vol. 127, Iss. 1, 2004-01 ,pp. : 233-234

Oxford University Press

Access to resources Recommend Favorite

Glycolysis Inhibition Decreases the Levels of Glutamate Transporters and Enhances Glutamate Neurotoxicity in the R6/2 Huntington′s Disease Mice

By Estrada-Sánchez Ana   Montiel Teresa   Massieu Lourdes  

Neurochemical Research, Vol. 35, Iss. 8, 2010-08 ,pp. : 1156-1163

Springer Publishing Company

Access to resources Recommend Favorite

Early detection of Huntington’’s disease

By Paulsen Jane S  

Future Neurology, Vol. 5, Iss. 1, 2010-01 ,pp. : 85-104

Future Medicine

Access to resources Recommend Favorite